- Home
- GNLX vs BANX Comparison
GNLX vs BANX Comparison
Compare GNLX & BANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- BANX
- Stock Information
- Founded
- GNLX 2001
- BANX 2013
- Country
- GNLX United States
- BANX United States
- Employees
- GNLX N/A
- BANX N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- BANX Trusts Except Educational Religious and Charitable
- Sector
- GNLX Health Care
- BANX Finance
- Exchange
- GNLX Nasdaq
- BANX Nasdaq
- Market Cap
- GNLX 128.0M
- BANX 146.9M
- IPO Year
- GNLX 2023
- BANX N/A
- Fundamental
- Price
- GNLX $3.95
- BANX $21.39
- Analyst Decision
- GNLX Strong Buy
- BANX
- Analyst Count
- GNLX 4
- BANX 0
- Target Price
- GNLX $17.75
- BANX N/A
- AVG Volume (30 Days)
- GNLX 134.7K
- BANX 23.4K
- Earning Date
- GNLX 11-13-2025
- BANX 06-17-2025
- Dividend Yield
- GNLX N/A
- BANX 9.66%
- EPS Growth
- GNLX N/A
- BANX N/A
- EPS
- GNLX N/A
- BANX 2.35
- Revenue
- GNLX N/A
- BANX $29,467,794.00
- Revenue This Year
- GNLX N/A
- BANX N/A
- Revenue Next Year
- GNLX N/A
- BANX N/A
- P/E Ratio
- GNLX N/A
- BANX $8.88
- Revenue Growth
- GNLX N/A
- BANX 2.73
- 52 Week Low
- GNLX $1.95
- BANX $17.99
- 52 Week High
- GNLX $5.89
- BANX $21.67
- Technical
- Relative Strength Index (RSI)
- GNLX 63.93
- BANX 66.31
- Support Level
- GNLX $3.56
- BANX $21.17
- Resistance Level
- GNLX $3.61
- BANX $21.35
- Average True Range (ATR)
- GNLX 0.24
- BANX 0.26
- MACD
- GNLX 0.03
- BANX 0.06
- Stochastic Oscillator
- GNLX 84.42
- BANX 99.66
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.